Scientists have developed “smart stethoscope” that could help to monitor the progress and effectiveness of the kidney stone therapy.
This research has been done by researchers from the University of Southampton and their collaborators, and has been published online in the journal Proceedings of the Royal Society A.
One of the favored procedures for the removal of kidney stones is lithotripsy. It is the medical fragmentation of a stone in the urinary system or gallbladder with the help of ultrasound shock waves, so that the pieces of stone could easily pass out of the body through urine or dissolved by drug. However, the difficulty occurs in the process of checking the stones in the body i.e. whether the stones broke and procedure has been completed or not.
With the help of this new “smart stethoscope” physicians could check whether the treatment for kidney stones work or not. This stethoscope is placed on the patient’s skin after shock wave treatment for kidney stones and it listens to the echoes reverberating around the body after the shock wave hits the stone. Read more…
Researchers have found that kidney transplant could result in increased chances of cancer.
This study has been conducted by Italian researchers and published online in the European Journal of Cancer.
Researchers in this study worked on 7,217 kidney transplant recipients, in whom the transplantation was done in the years between 1997 and 2007, and followed up until 2009.
Researchers found that 395 patients were diagnosed with de novo cancers including Kaposi’s sarcoma (KS), post-transplant lymphoproliferative disorders (PTLD), particularly non-Hodgkin’ lymphoma (NHL), lung, kidney and prostate as the most common types.
If we consider the geographical distribution, researchers have reported that the kidney transplant recipients from Southern Italy have decreased chances of kidney cancer and solid tumors while they are at increased risk of Kaposi’s sarcoma as compared to the recipients born in Northern Italy. Read more…
Researchers have found that black patients of kidney problem i.e. end stage renal disease (ESRD) had a 59% reduced rate of kidney transplant as compared to white patients in a southeastern Emory Transplant Center.
This research has been conducted by Rachel Patzer, PhD, of Emory University in Atlanta, and colleagues, and published online in January 10 issue of the American Journal of Transplantation.
Researchers worked on 2291 patients at Emory transplant center as well as those from the United States Renal Data System and the United Network for Organ Sharing, from 2005 to 2007 followed through May 2010, and found “racial disparities” in access to transplant evaluation, referral, wait-listing and eventual transplant. “Of 2291 patients, 64.9% were black, the mean age was 49.4 years and 33.6% lived in poor neighborhoods.” Among them 57.3% were male and 16.1% were without any health insurance coverage. Read more…
The drug is helpful for kidney transplant patients, if it is used with other immunosuppressants such as corticosteroids, mycophenolate mofetil and basiliximab. (Immunosuppressants are those drugs which cause reduction of immunity of the body). Read more…
(Following article contains research ideas about the possible causes of Hypertension and are contributed by Faizan Malik. He is one of the most talented students of Hajvery University having a very good research mind.)
A. Primary or “Essential” Hypertension
1. Etiology – unknown
2. Accounts for approximately 90% of hypertension
3. Onset typically in the fifth or sixth decade of life
4. Strong family history – 70-80% positive family history Read more…